https://www.prnewswire.com/news-releases/auravax-therapeutics-inc-receives-grant-for-viral-challenge-study-of-new-broad-acting-host-directed-therapeutic-302555234.html
AuraVax Therapeutics Inc. receives grant for viral challenge study of new broad acting...
/PRNewswire/ -- AuraVax Therapeutics, Inc. has received funding from the Gates Foundation to evaluate the efficacy of NanoSTING-001 in a swine disease model...
https://www.auravax.com/
Home - AuraVax
May 8, 2025 - Treatment and prevention of multiple respiratory pathogens For seasonal outbreaks and biothreats For civilian population and military personnel For medically...